Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies

Leukemia Research

Volumn 30, Issue 10, 2006, Pages 1241-1248

  Wihlidal, Peter ^a   Varga, Franz ^a   Pfeilstöcker, Michael ^a   Karlic, Heidrun ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Hematological malignancy; Osteocalcin, c KIT; Runt domain transcription factors

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; OSTEOCALCIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW EXAMINATION; CANCER PATIENT; CELL ACTIVATION; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STEM CELL;

ALTERNATIVE SPLICING; BONE MARROW CELLS; DISEASE PROGRESSION; DNA PRIMERS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MYELOPROLIFERATIVE DISORDERS; OSTEOCALCIN; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION, GENETIC;

EID: 33747337490     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.11.008     Document Type: Article

References (47)

1. Glowacki J., Rey C., Glimcher M.J., Cox K.A., and Lian J. A role for osteocalcin in osteoclast differentiation. J Cell Biochem 45 3 (1991) 292-302
2. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83 3 (2005) 170-179
3. Rammelt S., Neumann M., Hanisch U., Reinstorf A., Pompe W., Zwipp H., et al. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res A 73A 3 (2005) 284-294
4. Watson K.E., Bostrom K., Ravindranath R., Lam T., Norton B., and Demer L.L. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93 5 (1994) 2106-2113
5. Thiede M.A., Smock S.L., Petersen D.N., Grasser W.A., Thompson D.D., and Nishimoto S.K. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135 3 (1994) 929-937
6. Huss R., and Moosmann S. The co-expression of CD117 (c-kit) and osteocalcin in activated bone marrow stem cells in different diseases. Br J Haematol 118 1 (2002) 305-312
7. Zhang R., Ducy P., and Karsenty G. 1,25-Dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 272 1 (1997) 110-116
8. Varga F., Spitzer S., and Klaushofer K. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D(3)) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. Calcif Tissue Int (2003)
9. Varga F., Spitzer S., Rumpler M., and Klaushofer K. 1,25-Dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. J Mol Endocrinol 30 1 (2003) 49-57
10. Lian J.B., Stein G.S., Stein J.L., and van Wijnen A.J. Transcriptional control of osteoblast differentiation. Biochem Soc Trans 26 1 (1998) 14-21
11. Jung C., Ou Y.C., Yeung F., Frierson Jr. H.F., and Kao C. Osteocalcin is incompletely spliced in non-osseous tissues. Gene 271 2 (2001) 143-150
12. Taichman R.S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105 7 (2005) 2631-2639
13. Fierro F., Boxberger S., Feldmann S., Schleyer E., Ehninger G., Illmer T., et al. Imanitib mesylate inhibits osteogenic differentiation an proliferation of human mesenchymal stem cells. Onkologie 28 Suppl. 3 (2005) 134
14. Banerjee C., Hiebert S.W., Stein J.L., Lian J.B., and Stein G.S. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93 10 (1996) 4968-4973
15. Geoffroy V., Ducy P., and Karsenty G. A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270 52 (1995) 30973-30979
16. Karlic H., Lohninger A., Laschan C., Lapin A., Bohmer F., Huemer M., et al. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med 81 7 (2003) 435-442
17. Schmittgen T.D., Zakrajsek B.A., Mills A.G., Gorn V., Singer M.J., and Reed M.W. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285 2 (2000) 194-204
18. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270 1 (1999) 41-49
19. Karlic H., Lohninger S., Koeck T., and Lohninger A. Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem 50 2 (2002) 205-212
20. 2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML). Stem Cells 19 4 (2001) 321-328
21. Weghofer M., Karlic H., and Haslberger A. Quantitative analysis of immune-mediated stimulation of tumor necrosis factor-alpha in macrophages measured at the level of mRNA and protein synthesis. Ann Hematol 80 12 (2001) 733-736
22. Ratajczak M.Z., Luger S.M., DeRiel K., Abrahm J., Calabretta B., and Gewirtz A.M. Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89 5 (1992) 1710-1714
23. Osato M. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 23 24 (2004) 4284-4296
24. Fairbrother W.G., and Chasin L.A. Human genomic sequences that inhibit splicing. Mol Cell Biol 20 18 (2000) 6816-6825
25. Sironi M., Menozzi G., Riva L., Cagliani R., Comi G.P., Bresolin N., et al. Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 32 5 (2004) 1783-1791
26. Hauschka P.V., and Carr S.A. Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry 21 10 (1982) 2538-2547
27. Kassem M., Kristiansen M., and Abdallah B.M. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95 5 (2004) 209-214
28. Hauschka P.V., Lian J.B., Cole D.E., and Gundberg C.M. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69 3 (1989) 990-1047
29. Huss R., Gatsios P., Graeve L., Lange C., Eissner G., Kolb H.J., et al. Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation. Cytokine 12 8 (2000) 1195-1204
30. Huss R., Weissinger E.M., Lange C., Gatsios P., Eissner G., Kolb H.J., et al. In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62(dok) protein. J Pathol 192 3 (2000) 363-372
31. Huss R., Hong D.S., McSweeney P.A., Hoy C.A., and Deeg H.J. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci USA 92 3 (1995) 748-752
32. Huss R., Hoy C.A., and Deeg H.J. Contact- and growth factor-dependent survival in a canine marrow-derived stromal cell line. Blood 85 9 (1995) 2414-2421
33. Zanjani E.D., Almeida-Porada G., Livingston A.G., Flake A.W., and Ogawa M. Human bone marrow CD34-cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 26 4 (1998) 353-360
34. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 5309 (1997) 71-74
35. Huss R. Perspectives on the morphology and biology of CD34-negative stem cells. J Hematother Stem Cell Res 9 6 (2000) 783-793
36. Thalmeier K., Meissner P., Moosmann S., Sagebiel S., Wiest I., and Huss R. Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice. Acta Haematol 105 3 (2001) 159-165
37. Osawa M., Hanada K., Hamada H., and Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273 5272 (1996) 242-245
38. Lange C., Kaltz C., Thalmeier K., Kolb H.J., and Huss R. Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell line. J Hematother Stem Cell Res 8 4 (1999) 335-342
39. Yokomizo T., Ogawa M., Osato M., Kanno T., Yoshida H., Fujimoto T., et al. Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells. Genes Cells 6 1 (2001) 13-23
40. Banerjee C., McCabe L.R., Choi J.Y., Hiebert S.W., Stein J.L., Stein G.S., et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66 1 (1997) 1-8
41. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 5 (1997) 747-754
42. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 5 (1997) 755-764
43. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 5 (1997) 765-771
44. Gronthos S., Chen S., Wang C.Y., Robey P.G., and Shi S. Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res 18 4 (2003) 716-722
45. Ohyashiki J.H., Ohyashiki K., Iwama H., Hayashi S., Toyama K., and Shay J.W. Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res 3 4 (1997) 619-625
46. Warner J.K., Wang J.C., Takenaka K., Doulatov S., McKenzie J.L., Harrington L., et al. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 19 10 (2005) 1794-1805
47. Enver T., Heyworth C.M., and Dexter T.M. Do stem cells play dice?. Blood 92 2 (1998) 348-352